The data showed that the level of serum occludin was not significantly different in the two groups (Fig. 3A, Table S1), implying that the level of serum occludin did not seem to distinguish the ischemic stroke patients from hemorrhagic stroke patients. This evidence concerns the gene OCLN and ischemic stroke.